Wikipedia
Vorsetuzumab
Vorsetuzumab is a monoclonal antibody developed by Seattle Genetics, designed for the treatment of cancer.
Chemical names are:
- Immunoglobulin G1, anti-(CD antigen CD70) (human-mouse monoclonal h1F6 heavy chain), disulfide with human-mouse monoclonal h1F6 light chain, dimer
- Immunoglobulin G1, anti-(human CD70 antigen ( CD27 ligand, Tumor necrosis